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Abstract
Introduction: The Nexfin device estimates arterial pressure by the volume clamp method through a finger
pneumatic cuff. It also allows to estimate cardiac index (CInoninv) by pulse contour analysis of the non-invasive
arterial pressure curve. We evaluated the ability of the device to track changes in cardiac index induced by a fluid
challenge.
Methods: We included 45 patients for whom a volume expansion (500 mL of saline infused over 30 min) was
planned. The volume expansion-induced changes in cardiac index measured by transpulmonary thermodilution
(CIinv, PiCCO device) and in CInoninv were recorded.
Results: In seven patients, the Nexfin could not record the arterial curve due to finger hypoperfusion. Considering
both the values obtained before and after volume expansion (n = 76 pairs of measurements), the bias (lower and
upper limits of agreement) between CIinv and CInoninv was 0.2 (-1.8 to 2.2) L/min/m
2. The mean change in CInoninv
was 10 ± 11%. The percentage error of CInoninv was 57%. The correlation between the changes in CIinv and CInoninv
observed during volume expansion was significant (P = 0.0002) with an r2 = 0.31.
Conclusions: The estimation of CI by the Nexfin device in critically ill patients is not reliable, neither for estimating
absolute values of CI nor for tracking its changes during volume expansion.
Introduction
Among the different devices that are available today for
estimating cardiac output, the Nexfin technology
(BMeye, Amsterdam, The Netherlands) is particularly
original. This device provides a non-invasive estimation
of cardiac output in two steps. First, this device allows a
continuous estimation of the arterial pressure curve
through the volume-clamp method [1]. For this purpose,
the device includes an inflatable cuff that is wrapped
around a finger. It also includes a photoplethysmographic
device that measures the diameter of the finger arteries.
At each systole, the photoplethysmographic device senses
the increase of the finger arteries’ diameter. A fast servo-
controlled system immediately inflates the cuff in order
to keep the arteries’ diameter constant. Therefore, cuff
pressure reflects the arterial pressure. Its continuous
measurement allows estimation of the arterial pressure
curve [2]. The second step is to estimate cardiac output
from the non-invasive arterial pressure curve. For this
purpose, the Nexfin device includes pulse contour analy-
sis software that computes cardiac output from the arter-
ial pressure curve [3].
The Nexfin has been quite largely validated for measur-
ing arterial pressure [4-10]. However, its reliability to
measure cardiac index (CI) has been mainly investigated
in non-critically ill patients [5,11-15]. Our aim was to
assess whether the Nexfin estimation of CI was able to
reflect CI in critically ill patients and to track its changes
during a fluid challenge.
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Materials and methods
Patients
This study took place in the medical and surgical intensive
care units of a university hospital. It was approved by the
institutional review board of our institution (Comité pour
la Protection des Personnes Ile-de-France VII). Informed
patient (or next-of-kin) consent was obtained from all
patients. Patients were prospectively included if they pre-
sented an acute circulatory failure for which the attending
physician had decided to administer fluid. This decision
was based on inadequate tissue perfusion defined by the
presence of at least one of the following signs [16-18]: (1)
systolic blood pressure <90 mmHg (or a decrease >50
mmHg in previously hypertensive patients) or the need for
norepinephrine, (2) urine output <0.5 mL/kg/hr for at
least 2 hrs, (3) tachycardia >100 beats/min, (4) skin mot-
tling or (5) blood lactate >2 mmol/L.
Hemodynamic measurements
All patients had an internal jugular vein catheter and a
thermistor-tipped arterial catheter (PV2024 Pulsion Medi-
cal Systems, Munich, Germany) in the femoral artery con-
nected to the PiCCO2 device (Pulsion Medical Systems,
Munich, Germany) to measure invasive cardiac index
(CIinv) and global end-diastolic volume (through transpul-
monary thermodilution). The femoral arterial line was
connected to the pressure sensor PV8115 (Pulsion Medi-
cal Systems, Munich, Germany) and the invasive arterial
pressure was measured by the PiCCO2 device. In addition,
all patients were monitored with a Nexfin device for mea-
suring non-invasive arterial pressure and CI (CInoninv). An
appropriate size finger cuff was applied around the middle
phalanx of the third finger and connected to the device. A
height sensor was fixed on one arm at the level of the
heart for allowing the device to automatically correct for
the hydrostatic pressure influences. If the arterial pressure
signal was not obtained from the third finger, another fin-
ger was used until a signal could be obtained. If no signal
could be obtained from any finger, efforts were made to
rewarm the hand before all fingers were tested again.
The Nexfin device continuously records the arterial
pressure curve and computes CInoninv by pulse contour
analysis. This analysis consists in estimating stroke
volume by dividing the area under the systolic part of the
arterial pressure curve by the aortic impedance [19]. Aor-
tic impedance is determined from a three-element Wind-
kessel model that incorporates the influence of non-
linear effects of arterial pressure and of patient’s age,
height, weight and gender on aortic mechanical proper-
ties [20]. The Nexfin method was developed on a data-
base including invasive and non-invasive finger arterial
pressures together with thermodilution cardiac output
values obtained during cardiac surgery [19,21], in healthy
subjects during passive head-up tilt [22] and with low
arterial pressure and treatment with catecholamines in
severe septic shock [23].
Study design
At baseline, we measured arterial pressure, heart rate,
CInoninv and transpulmonary thermodilution variables
including CIinv and global end-diastolic volume. Immedi-
ately after, volume expansion was performed by infusing
500 mL of saline over 30 min. After volume expansion,
we again recorded arterial pressure, heart rate, invasive
and non-invasive arterial pressure, CInoninv and transpul-
monary thermodilution variables including CIinv and glo-
bal end-diastolic volume. Patients in whom volume
expansion increased CI by more than 15% were defined
as ‘volume responders’ and the remaining ones as ‘non-
volume responders’ [16-18,24].
Statistical analysis
The normality of data distribution was tested with the
Anderson-Darling test. Data are expressed as mean ±
standard deviation (SD) or median (interquartile range),
as appropriate. CIinv was considered as the reference
technique [25,26]. Values of invasive vs. non-invasive
mean arterial pressure and of CIinv vs. CInoninv were com-
pared by the Bland-Altman analysis. The percentage
error was calculated as two times SD divided by the
mean of the reference method [27]. Comparisons of
hemodynamic variables between the different study times
were assessed using a paired Student t test or a Wilcoxon
test, as appropriate. Comparisons between volume
responders vs. non-volume responders were assessed
using a two sample Student t test or a Mann-Whitney U
test, as appropriate. We compared the relative changes of
CIinv to those of CInoninv during volume expansion by lin-
ear regression analysis (for percent changes). For asses-
sing the trending ability of CInoninv, we constructed a
four-quadrant plot, as described by Critchley et al. [28].
This allowed calculation of the percentage of total data
points for which the directional changes of CInoninv
(increase or decrease) was concordant with those of
CIinv. According to the least significant change of CIinv
[29], we applied a 15% exclusion zone. Correlations were
assessed by the Pearson coefficient. A P value <0.05 was
considered statistically significant. The statistical analysis




Forty-five patients were included in the study. Seven
patients were excluded because the arterial curve was
not obtainable from the Nexfin device, likely due to
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excessive vasoconstriction. All these seven patients
exhibited clinical signs of severe skin hypoperfusion. In
these patients, the mean arterial pressure was 43 ± 7
mmHg, cardiac index before the fluid challenge was 2.9
± 0.5 L/min/m2 and the dose of norepinephrine was 3.8
(2.1 to 6.7) µg/kg/min. On average, the study was con-
ducted 252 (20 to 6520) min after the beginning of the
shock episode.
The characteristics of the 38 patients who could be
analyzed are summarized in Table 1. Fifty-three percent
of patients presented spontaneous breathing activity and
13% presented atrial fibrillation. Volume expansion sig-
nificantly increased CIinv by more than 15% (27 ± 7%)
in 16 volume responders (Table 2).
Non-invasive estimation of mean arterial pressure
Considering both the values obtained before and after
volume expansion in all patients (n = 76 pairs of measure-
ments), the bias (lower and upper limits of agreement)
between the invasive and non-invasive measurements of
mean arterial pressure was 2 (-18 to 23) mmHg (Figure 1).
Non-invasive estimation of cardiac index
Considering both values obtained before and after volume
expansion (n = 76 pairs of measurements), the bias (lower
and upper limits of agreement) between CIinv and CInoninv
was 0.2 (-1.8 to 2.2) L/min/m2 (Figure 2). The percentage
error of CInoninv was 57%. The correlation between the
percent changes in CIinv and CInoninv observed during
volume expansion was significant (P = 0.0002) with an r2
= 0.31 (Figure 3). The results of Bland-Altman analysis in
patients without atrial fibrillation or norepinephrine
administration are presented in Table 3.
The concordance rate between changes in CIinv and
CInoninv induced by volume expansion was 76% (Figure 3),
meaning that in 76% of instances, CIinv and CInoninv chan-
ged in the same direction. When excluding changes lower
than 15%, the concordance rate was 84% (Figure 3).
An increase in CInoninv ≥15% allowed to detect volume
responsiveness, that is, an increase in CIinv ≥15%, with a
sensitivity of 43% (95% confidence interval: 20 to 70%), a
specificity of 95% (77 to 100%), a positive predictive value
of 88% (44 to 100%) and a negative predictive value of
70% (51 to 85%).
Discussion
The main finding of this study was that the non-invasive
estimation of cardiac output provided by the Nexfin
method was not reliable compared to transpulmonary
thermodilution in critically ill patients even though, dur-
ing volume expansion, CInoninv and CInoninv often chan-
ged in the same direction.
In the recent years, many efforts have been made to
develop new techniques for monitoring cardiac output,
with the particular aim of reducing their invasiveness. In
this regard, the Nexfin technique seems particularly seduc-
tive since it only requires a finger pneumatic cuff. Never-
theless in the present study, we found that the Nexfin
device was not reliable to estimate the absolute value of
cardiac output. The Bland-Altman analysis showed a wide
range for limits of agreement and the percentage error,
which must be below 30% if transpulmonary thermodilu-
tion is used as the reference technique [27,29], was much
higher. More than in a given value of cardiac output, clini-
cians might be more interested in cardiac output changes.
In this regard also, the Nexfin estimation of cardiac output
was not reliable. Indeed, the correlation between CInoninv
and CIinv was only weak. If analyzing this trending ability
by a four-quadrant approach, as proposed by Critchley et
al. [28], we found that the concordance rate was 84%
when excluding from analysis changes in cardiac output
that were too small to have any technological significance.
It means that, in a majority of cases, CIinv and CInoninv
changed in the same direction, which would suggest a
good trending ability of CInoninv. Nonetheless, this four-
quadrant analysis only takes into account the direction of
cardiac output changes and not their magnitude, that is, it
only allows a rough evaluation. For clinical practice, not
only the direction but also the amplitude of CI changes
Table 1 Characteristics of patients.
Age 65 ± 15
(mean ± SD, years)
Gender 20/18
(male/female, number of patients)
SAPS II 55 ± 15
(mean ± SD)
Acute respiratory distress syndrome 16 (42%)
(number of patients, %)
Atrial fibrillation 5 (13%)
(number of patients, %)
Spontaneous breathing activity 20 (53%)
(number of patients, %)
Tidal volume 6.1 ± 1.3
(mean ± SD, mL/kg of predicted body weight)
Patients receiving norepinephrine 17 (45%)
(number of patients, %)
Body temperature 37.8 ± 1.4
(mean ± SD, °C)
Type of shock
(number of patients, %)
Septic 33 (87%)
Hypovolemic 5 (13%)
Dose of norepinephrine 0.4 (0.21-0.60)
(median (interquartile range), µg/kg/min)
n = 38. SAPS, simplified acute physiology score.
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might be important. For instance, the response to a fluid
challenge is assessed by precisely measuring the relative
change in CI that it induces. In this regard, we report a
poor ability of CInoninv to detect a positive response to
fluid administration, in particular with a low sensitivity.
This poor reliability of the Nexfin device to estimate car-
diac output is in discrepancy with some previous results
obtained with the same technique [5,11-15,30]. A recent
publication also reported a good ability of the Nexfin
device to estimate cardiac output measured by transpul-
monary thermodilution as well as its changes observed
over time or during a passive leg-raising test [6]. The most
plausible hypothesis explaining the discrepancy of such
previous results with our findings is the difference in the
population of interest. The studies that demonstrated a
better reliability of the Nexfin were conducted in the oper-
ating theatre [11,12], in cardiac surgery patients after
discontinuation of mechanical ventilation and inotropes
[5], in patients undergoing resynchronization therapy [14],
in an echocardiography laboratory [13] or in healthy sub-
jects [15]. By contrast, in the present study, we included
critically ill patients, a majority suffering from septic
shock. Interestingly, our results are in agreement with
another study reporting a poor reliability of the Nexfin
and that was also conducted in intensive care unit patients
[31]. In fact, such patients are much more likely to have
an impaired finger perfusion, due either to endogenous
sympathetic stimulation, to norepinephrine administration
or to sepsis-related microcirculatory abnormalities. In this
regard, the fact that the reliability of the Nexfin device was
not different between patients with and without norepi-
nephrine suggests that exogenous amines administered
might not be the only factor explaining a poor finger per-
fusion in such critically ill patients. Poor finger perfusion
Table 2 Hemodynamic changes induced by volume expansion.
Before volume expansion After volume expansion
Heart rate volume responders (n = 16) 104 ± 33 110 ± 28
(mean ± SD, beats/min) non-volume responders (n = 22) 98 ± 20 96 ± 22
Invasive mean arterial pressure volume responders (n = 16) 77 ± 16 80 ± 20#
(mean ± SD, mmHg) non-volume responders (n = 22) 74 ± 14 79 ± 14
Non-invasive mean arterial pressure volume responders (n = 16) 75 ± 17 80 ± 18#
(mean ± SD, mmHg) non-volume responders (n = 22) 70 ± 16 76 ± 19#
Invasive cardiac index volume responders (n = 16) 3.2 ± 0.9 3.9 ± 1.0#
(mean ± SD, L/min/m2) non-volume responders (n = 22) 3.8 ± 9.0 3.8 ± 1.1
Non-invasive cardiac index volume responders (n = 16) 3.2 ± 1.2 3.6 ± 1.1#
(mean ± SD, L/min/m2) non-volume responders (n = 22) 3.4 ± 1.0 3.6 ± 1.0
Global end-diastolic volume volume responders (n = 16) 726 ± 112 767 ± 111#
(mean ± SD, mL/m2) non-volume responders (n = 22) 799 ± 137 814 ± 156
#P <0.05 vs. ‘before volume expansion’.
Figure 1 Bland-Altman plot for the absolute values of mean
arterial pressure obtained from the Nexfin device (MAPnoninv)
and from the femoral arterial catheter (MAPinv) considering all
the pairs of measurements performed during the study. N = 72;
straight line, bias; dashed line, +2D/-2SD limits of agreement.
Figure 2 Bland-Altman plot for the absolute values of cardiac
index obtained from the Nexfin device (CInoninv) and from
transpulmonary thermodilution (CIinv) considering all the pairs
of measurements performed during the study. N = 72; straight
line, bias; dashed line, +2D/-2SD limits of agreement.
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very likely impedes a correct assessment of the finger pres-
sure curve by the volume-clamp method, which includes
an analysis of the finger photoplethysmographic signal. In
this regard, we observed that the non-invasive arterial
pressure curve was not obtainable in a relatively large pro-
portion of our patients. We made a similar observation
with another volume-clamp device in a similar population
[32]. This suggests that such a limitation is inherent to
all these techniques of non-invasive arterial pressure
assessment.
With the Nexfin device in the present study, we could
not determine whether the poor reliability of estimation
of cardiac output was related to a poor assessment of the
arterial pressure curve or to a failure of the pulse contour
analysis process since this proprietary process was
unknown to us. Nevertheless, we hypothesize that the
pulse contour analysis did not account a lot for the
results. Indeed, the therapeutic intervention we used, that
is, volume expansion, is known to alter the pulse contour
analysis to a lesser extent than treatments modifying the
properties of the arterial tree, such as vasoactive agents
[33-35].
The estimation of arterial pressure by the Nexfin techni-
que is based on the old volume-clamp method [1] but also
includes an individual calibration technique (Physiocal)
developed by Wesseling et al. [36]. Compared with the
previous Finapress device, the Nexfin device has benefited
from many technological improvements [7]. It has been
reported to reliably estimate arterial pressure [4-10]. In the
present study, the assessment of such reliability was based
only on the comparison of mean arterial pressures pro-
vided by the Nexfin vs. the arterial line. Indeed, due to the
pulse wave amplification phenomenon, the systolic and
diastolic values of arterial pressure are physiologically dif-
ferent between the brachial pressure, estimated by the
Nexfin device, and the femoral pressure that we invasively
measured. By contrast, the mean arterial pressure is almost
constant along the arterial tree and we used it for assessing
the reliability of the Nexfin arterial pressure estimation.
The bias between non-invasive and invasive mean arterial
pressures was low, while the limits of agreement were rela-
tively high. Previous studies reported better results for this
device [4-10]. Like for the estimation of cardiac output,
these different results might be explained by the fact that
we included patients with septic shock receiving vasopres-
sors, in whom the analysis of the non-invasive arterial
pressure curve might be difficult due to a poor finger per-
fusion. The fact that the Nexfin device was of poorer relia-
bility in critically ill patients than reported in the
perioperative setting [5,11,12] suggests that such a device
is more suitable for the operating theatre than for inten-
sive care units.
A first limitation of our study is that we could not
investigate the ability of the Nexfin device to estimate
pulse pressure variation, as we did for a similar device
in a previous study [32]. This was due to the fact that
we included a majority of patients in whom pulse pres-
sure variation is of difficult measurement and interpreta-
tion, that is, spontaneous breathing activity and/or
cardiac arrhythmias and/or acute respiratory distress
syndrome [37,38]. Also, although the manufacturer
recommends that the finger cuff should be applied to
the middle phalanx of the second or third fingers, it was
not the case in all the patients of the study since the
position of the cuff was changed when the arterial pres-
sure could not be obtained from the third finger. In
addition, we cannot exclude that when the patient’s
hand was rewarmed, this could have distorted the Nex-
fin measurement by changing the microcirculation.
Figure 3 Trending ability of the cardiac index obtained from
the Nexfin device (ΔCInoninv) against cardiac index measured
by transpulmonary thermodilution (ΔCIinv) during volume
expansion based on four-quadrant concordance analysis.
Table 3 Bland-Altman analysis for the comparison between cardiac index measured by the Nexfin device and
transpulmonary thermodilution depending upon the absence of atrial fibrillation and norepinephrine infusion.
Subgroup Bias
(L/min/m2)
Upper limit of agreement
(L/min/m2)
Lower limit of agreement
(L/min/m2)
Percentage error
Whole population (n = 38) 0.2 -1.8 2.2 57%
Patients without atrial fibrillation (n = 33) 0.3 -1.8 2.4 57%
Patients without norepinephrine (n = 21) 0.3 -1.8 2.3 62%
Monnet et al. Critical Care 2012, 16:R212
http://ccforum.com/content/16/5/R212
Page 5 of 7
Finally, although we hypothesize that the discrepancy
between the present study and previous publications
was related to the type of included patients, we did not
directly compare the device in similar conditions
between critically ill and perioperative patients. Such a
comparison remains to be performed.
Conclusions
The estimation of cardiac output by the Nexfin device
in critically ill patients is not reliable, neither for esti-
mating absolute values of cardiac output nor for track-
ing its changes during volume expansion.
Key messages
• The estimation of cardiac index by the volume-
clamp method in critically ill patients was not reliable.
• The method could not reliably track the changes in
cardiac index induced by volume expansion.
• Due to finger hypoperfusion, the technique could not
estimate cardiac index in a relatively large proportion
of these patients with an acute circulatory failure.
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